Article Text

Download PDFPDF
Misoprostol in a topsyturvy world
  1. D O E Gebhardt, PhD
  1. Retired biochemist Anna van Burenlaan 1, 2341 VE Oegstgeest The Netherlands

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


    In the January 4 issue of the New England Journal of Medicine three articles appeared on the unapproved use of Misoprostol (Cytotec), which raise an interesting ethical question. The synthetic prostaglandin analogue, Misoprostol, has been successfully used by obstetricians and gynaecologists for a number of years for the induction of a medical abortion in the first or second trimester, for the induction of labour, and for the prevention of postpartum haemorrhages.1 Strangely enough the pharmaceutical company which produces and markets the drug, Searle, …

    View Full Text